Data show that intra‐VMN DAB administration to eu‐ or hypoglycemia animals did not modify circulating glucose and glucagon concentrations, despite alterations in gluco‐regulatory neurotransmitter enzyme/neuropeptide expression. The gene discussed is GCG; the disease is Hypoglycemia.